Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,928 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.
Robertson AG, Meghani K, Cooley LF, McLaughlin KA, Fall LA, Yu Y, Castro MAA, Groeneveld CS, de Reyniès A, Nazarov VI, Tsvetkov VO, Choy B, Raggi D, Marandino L, Montorsi F, Powles T, Necchi A, Meeks JJ. Robertson AG, et al. Among authors: montorsi f. Nat Commun. 2023 Apr 27;14(1):2126. doi: 10.1038/s41467-023-37568-9. Nat Commun. 2023. PMID: 37105962 Free PMC article.
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis.
Barletta F, Tappero S, Panunzio A, Incesu RB, Cano Garcia C, Piccinelli ML, Tian Z, Gandaglia G, Moschini M, Terrone C, Antonelli A, Tilki D, Chun FKH, De Cobelli O, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Barletta F, et al. Among authors: montorsi f. Urol Oncol. 2023 Mar;41(3):147.e1-147.e6. doi: 10.1016/j.urolonc.2022.10.027. Epub 2022 Nov 22. Urol Oncol. 2023. PMID: 36428165
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review.
Basile G, de Angelis M, Leni R, Re C, Longoni M, Mari A, Soria F, Pradere B, Del Giudice F, Laukhtina E, D'Andrea D, Mori K, Krajewski W, Albisinni S, Gallioli A, Breda A, Esperto F, Briganti A, Montorsi F, Moschini M, Carando R; European Association of Urology - Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Basile G, et al. Among authors: montorsi f. Minerva Urol Nephrol. 2023 Jun;75(3):278-288. doi: 10.23736/S2724-6051.23.05091-7. Epub 2023 Mar 22. Minerva Urol Nephrol. 2023. PMID: 36946716 Free article.
Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients.
Tappero S, Sorce G, Panunzio A, Hohenhorst L, Garcia CC, Piccinelli ML, Tian Z, Parodi S, Chun FKH, Graefen M, Antonelli A, De Cobelli O, Saad F, Shariat SF, Montorsi F, Suardi NR, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: montorsi f. Cent European J Urol. 2022;75(4):352-356. doi: 10.5173/ceju.2022.142. Epub 2022 Nov 25. Cent European J Urol. 2022. PMID: 36794025 Free PMC article.
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment.
Bianchi L, Ceci F, Balestrazzi E, Costa F, Droghetti M, Piazza P, Pissavini A, Presutti M, Farolfi A, Mei R, Castellucci P, Gandaglia G, Larcher A, Robesti D, Mottrie A, Briganti A, Morganti AG, Fanti S, Montorsi F, Schiavina R, Brunocilla E. Bianchi L, et al. Among authors: montorsi f. Cancers (Basel). 2023 Mar 29;15(7):2027. doi: 10.3390/cancers15072027. Cancers (Basel). 2023. PMID: 37046687 Free PMC article.
Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer.
Pellegrino F, Mazzone E, Stabile A, Beauval JB, Marra G, Campi R, Afferi L, Zhuang J, Sorce G, Rosiello G, Barletta F, Scuderi S, Guo H, Gontero P, Minervini A, Ploussard G, Montorsi F, Briganti A, Gandaglia G. Pellegrino F, et al. Among authors: montorsi f. Urol Oncol. 2023 Sep;41(9):387.e17-387.e25. doi: 10.1016/j.urolonc.2023.04.019. Epub 2023 May 16. Urol Oncol. 2023. PMID: 37198026
Minimally invasive transperitoneal partial versus radical nephrectomy in obese patients: perioperative and long-term functional outcomes from a large perspective contemporary series (RECORd2 project).
Lambertini L, Mari A, Sandulli A, Amparore D, Antonelli A, Barale M, Bove P, Brunocilla E, Capitanio U, DA Pozzo LF, DI Maida F, Grosso AA, Fiori C, Gontero P, Li Marzi V, Campi R, Longo N, Marchioni M, Montanari E, Montorsi F, Porpiglia F, Porreca A, Schiavina R, Simeone C, Siracusano S, Terrone C, Ficarra V, Minervini A. Lambertini L, et al. Among authors: montorsi f. Minerva Urol Nephrol. 2024 Apr;76(2):185-194. doi: 10.23736/S2724-6051.24.05692-1. Minerva Urol Nephrol. 2024. PMID: 38742553
1,928 results